Past Newsletters
Signs of Multiple Sclerosis Show Up in Blood Years Before Symptoms
In a discovery that could hasten treatment for patients with multiple sclerosis (MS), UC San Francisco scientists have discovered a harbinger in the blood of some people who later went on to develop the disease.
Targeted Therapy, Treatment Disparity Featured at Cancer Meeting
Leading cancer researchers from UC San Francisco presented talks about advances in targeted therapy, cancer genomics, eliminating treatment disparities and other cancer research topics at this year’s annual meeting of the American Association ...
Can a New Drug Candidate Cure Pancreatic Cancer?
UC San Francisco researchers have designed a candidate drug that could help make pancreatic cancer, which is almost always fatal, a treatable, perhaps even curable, condition.
New Predictive MS Blood Test May Help Prevent Disability Worsening
Patients with multiple sclerosis (MS) whose blood tests reveal elevated neurofilament light chain (NfL), a biomarker of nerve damage, are at risk of experiencing disability worsening one to two years later, according to a new study spearheaded ...
Novel Tricuspid Valve Procedure Improve Patients' Quality of Life and Health Status
UC San Francisco interventional cardiologists and interventional echocardiographers recently performed the health system’s first commercial transcatheter tricuspid valve replacement procedure using the Edwards Evoque system.
Can AI Predict Serious Adverse Events From IBD Therapies?
In a groundbreaking study, UCSF researchers used a new clinical large language model (LLM) to identify serious adverse events (SAEs) occurring in patients treated with immunosuppressants to manage inflammatory bowel disease (IBD).
Gene Therapy Is Halting Cancer. Can It Work Against Brain Tumors?
Approximately 12,000 Americans are diagnosed each year with glioblastoma. Patients survive on average for just 15 months after their diagnosis, and new treatments are urgently needed.
New Alzheimer’s Trial to Combine Anti-Amyloid and Anti-Tau Therapies to Arrest Disease Progression
A new study will combine an Alzheimer’s medication that slows disease progression in some patients with two drugs that target disease-driving proteins to see whether their effects can be amplified.
How a Cardiogenic Shock Rapid Transfer Protocol Enables Lifesaving Patient Care: Case Study
UCSF has a rapid transfer protocol in place, which includes immediate access to a critical care cardiologist, expedited triage and a dedicated unit for patients transferring in for emergent care.
First-of-its-Kind Amputation Prevention Center Offers Hope for the Toughest Cases
Rogelio Jacinto had five days until doctors planned to amputate his leg. It was an emotionally wrenching end to five months of unsuccessful visits to specialists to treat a diabetic foot ulcer.
150 Milestone: Robotic Procedure Changes Prostate Cancer Care
UCSF Health has performed 150 robotic focal high-intensity focused ultrasound (HIFU) procedures for patients living with prostate cancer, becoming the first on the West Coast and the first UC Health System to reach that milestone.
Physician Survey Shows Lack of Understanding of the FDA’s Approval Process
Many physicians are unfamiliar with how the Food and Drug Administration’s (FDA) regulates new drugs and medical devices, and they may be under the impression that the data supporting these approvals are more rigorous than they are, according ...
Study Finds Paxlovid Treatment Does Not Reduce Risk of Long COVID
A team of researchers from UC San Francisco has found that Paxlovid (Nirmatrelvir-ritonavir) did not reduce the risk of developing long COVID for vaccinated, non-hospitalized individuals during their first COVID-19 infection.
Adult Acquired Buried Penis: Improving Patient Outcomes
Adult-acquired buried penis (AABP) is a condition in which excess or abnormal surrounding soft tissue covers the penis, resulting in sexual and urinary dysfunction. While it’s associated with obesity, AABP does not typically subside with weight loss.
Is Regenerative Medicine the Next Generation of Infertility Treatment?
Failed or canceled frozen embryo transfer (FET) cycles often occur in patients with thin endometrial linings. Existing treatments to increase lining thickness, such as hormone therapy, are not always effective, leaving some patients with ...